Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 92
Filter
1.
Cardiol Young ; 34(2): 314-318, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37403735

ABSTRACT

The use of prostaglandin E1 is well documented in ductus arteriosus-dependent CHD or in neonatal pulmonary pathologies that cause severe pulmonary hypertension. The intravenous infusion is well established in loading infusion and maintenance with an onset of action of 30 minutes until 2 hours or even more. Our aim is to report three patients with pulmonary atresia that presented hypercyanotic spell due to a ductal spasm during cardiac catheterisation in whom the administration of a bolus of alprostadil reversed the spasm and increased pulmonary flow, immediately stabilising the condition of the patients allowing subsequent successful stent placement with no serious complications or sequelae after the administration of the bolus. More studies are needed to make a recommendation regarding the use of alprostadil in bolus in cases where the ductal spasm might jeopardise the life of the patient.


Subject(s)
Ductus Arteriosus, Patent , Ductus Arteriosus , Heart Defects, Congenital , Infant, Newborn , Humans , Alprostadil/therapeutic use , Ductus Arteriosus, Patent/drug therapy , Spasm
2.
Lipids Health Dis ; 22(1): 43, 2023 Mar 28.
Article in English | MEDLINE | ID: mdl-36978188

ABSTRACT

BACKGROUND AND AIM: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations in genes involved in chylomicron metabolism. On the other hand, multifactorial chylomicronemia syndrome (MCS) is a polygenic disorder and the most frequent cause of chylomicronemia, which results from the presence of multiple genetic variants related to chylomicron metabolism, in addition to secondary factors. Indeed, the genetic determinants that predispose to MCS are the presence of a heterozygous rare variant or an accumulation of several SNPs (oligo/polygenic). However, their clinical, paraclinical, and molecular features are not well established in our country. The objective of this study was to describe the development and results of a screening program for severe hypertriglyceridemia in Colombia. METHODS: A cross-sectional study was performed. All patients aged >18 years with triglyceride levels ≥500 mg/dL from 2010 to 2020 were included. The program was developed in three stages: 1. Review of electronic records and identification of suspected cases based on laboratory findings (triglyceride levels ≥500 mg/dL); 2. Identification of suspected cases based on laboratory findings that also allowed us to exclude secondary factors; 3. Patients with FCS scores <8 were excluded. The remaining patients underwent molecular analysis. RESULTS: In total, we categorized 2415 patients as suspected clinical cases with a mean age of 53 years, of which 68% corresponded to male patients. The mean triglyceride levels were 705.37 mg/dL (standard deviation [SD] 335.9 mg/dL). After applying the FCS score, 2.4% (n = 18) of patients met the probable case definition and underwent a molecular test. Additionally, 7 patients had unique variants in the APOA5 gene (c.694 T > C; p. Ser232Pro) or in the GPIHBP1 gene (c.523G > C; p. Gly175Arg), for an apparent prevalence of familial chylomicronemia in the consulting population of 0.41 per 1.000 patients with severe HTG measurement. No previously reported pathogenic variants were detected. CONCLUSION: This study describes a screening program for the detection of severe hypertriglyceridemia. Although we identified seven patients as carriers of a variant in the APOA5 gene, we diagnosed only one patient with FCS. We believe that more programs of these characteristics should be developed in our region, given the importance of early detection of this metabolic disorder.


Subject(s)
Hyperlipoproteinemia Type IV , Hyperlipoproteinemia Type I , Hypertriglyceridemia , Humans , Male , Middle Aged , Hyperlipoproteinemia Type I/diagnosis , Hyperlipoproteinemia Type I/genetics , Cross-Sectional Studies , Lipoprotein Lipase/genetics , Colombia/epidemiology , Hypertriglyceridemia/epidemiology , Hypertriglyceridemia/genetics , Hypertriglyceridemia/complications , Triglycerides , Chylomicrons
3.
Cardiol Young ; 33(12): 2649-2650, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37905344

ABSTRACT

Ten-day-old neonate who underwent correction of interrupted aortic arch developed a giant early post-surgical aneurysm. To our knowledge, this unusual complication has been only reported as a late complication.


Subject(s)
Aneurysm , Aortic Coarctation , Infant , Infant, Newborn , Humans , Aorta, Thoracic/diagnostic imaging , Aorta, Thoracic/surgery , Aortic Coarctation/surgery
4.
Int J Mol Sci ; 24(18)2023 Sep 12.
Article in English | MEDLINE | ID: mdl-37762277

ABSTRACT

Aberrant expression of the tight junction protein claudin 6 (CLDN6) is a hallmark of gastric cancer progression. Its expression is regulated by the cAMP response element-binding protein (CREB). In gastric cancer induced by Helicobacter pylori (H. pylori) there is no information regarding what transcription factors induce/upregulate the expression of CLDN6. We aimed to identify whether CREB and Yin Yang1 (YY1) regulate the expression of CLDN6 and the site where they bind to the promoter sequence. Bioinformatics analysis, H. pylori lipopolysaccharide (LPS), YY1 and CREB silencing, Western blot, luciferase assays, and chromatin immunoprecipitation experiments were performed using the stomach gastric adenocarcinoma cell line AGS. A gen reporter assay suggested that the initial 2000 bp contains the regulatory sequence associated with CLDN6 transcription; the luciferase assay demonstrated three different regions with transcriptional activity, but the -901 to -1421 bp region displayed the maximal transcriptional activity in response to LPS. Fragment 1279-1421 showed CREB and, surprisingly, YY1 occupancy. Sequential Chromatin Immunoprecipitation (ChIP) experiments confirmed that YY1 and CREB interact in the 1279-1421 region. Our results suggest that CLDN6 expression is regulated by the binding of YY1 and CREB in the 901-1421 enhancer, in which a non-described interaction of YY1 with CREB was established in the 1279-1421 region.


Subject(s)
Adenocarcinoma , Helicobacter pylori , Stomach Neoplasms , Humans , Cyclic AMP Response Element-Binding Protein/genetics , Lipopolysaccharides/pharmacology , YY1 Transcription Factor/genetics
5.
Langmuir ; 38(48): 14540-14549, 2022 Dec 06.
Article in English | MEDLINE | ID: mdl-36399119

ABSTRACT

We implement molecular dynamics (MD) simulations to explore the relaxation mechanisms involved in the description of translational diffusion and rotational dynamics in water/hydrocarbon interfaces. The analysis of density profiles, self-diffusion coefficients, and nuclear magnetic resonance (NMR) relaxation properties as a function of the confinement layer width and type of hydrocarbons improves the understanding of confined water properties at water/oil interfaces. Density profile fluctuations reveal the presence of water-oil interactions close to the interface. MD results show that self-diffusion coefficients and NMR relaxation times of planar and cylindrical water/oil interfaces are strongly influenced by layer thickness and geometry. Shorter (between 20 and 60%) self-diffusion coefficients and 1H NMR relaxation times were obtained for water/n-pentane, water/n-decane, and water/n-hexadecane systems than bulk diffusion coefficients. An increase in Larmor frequency from 2.3 MHz to 400 MHz shows that longitudinal relaxation time (T1) of confined oil has slightly larger differences at higher frequencies than the transverse relaxation time (T2). At 400 MHz, n-alkanes (n-pentane, n-decane, and n-hexadecane) exhibit longer relaxation times than at smaller frequency values (2.3 and 22 MHz). Analysis of spin-spin and spin-lattice times provides relevant information about inter- and intramolecular relaxation mechanisms of water and oil as a function of geometry and width of the interface layer. These MD results suggest that the strength of confinement and geometry play a vital role in the diffusion and NMR relaxation properties of water/oil interfaces.

6.
Rev Chil Pediatr ; 91(3): 379-384, 2020 Jun.
Article in Spanish | MEDLINE | ID: mdl-32730518

ABSTRACT

INTRODUCTION: The treatment of advanced neuroblastoma includes chemotherapy, surgery, and radiotherapy with 131-I-Metaiodobenzylguanidine (131-I-MIBG). Despite strategies to protect thyroid function, its dysfunction is reported between 12 and 85%. OBJECTIVE: To identify the frequency of thyroid dys function in cases of neuroblastoma treated with 131-I-MIBG. PATIENTS AND METHOD: Cross-sectional study. We included all the cases with neuroblastoma treated with 131-I-MIBG between 2002 and 2015, with complete somatometry, and complete thyroid profile (TSH, free and total T3 and T4, and anti-thyroglobulin and antiperoxidase antibodies). RESULTS: 27 patients were identified out of which eleven died (40%). Out of the 16 surviving cases, 9 (56%) presented thyroid dysfunction: 2 (13%) cases with subclinical hypothyroidism and 7 (44%) cases with clinical hypothyroidism (3 cases due to psychomotor developmental delay and 4 due to growth deceleration). The patients presented cli nical manifestations at 16.1 months (1.2-66.3 months) after receiving the radiopharmaceutical at a cumulative dose of 142 mCi (96-391.5 mCi). No differences were found in the age at diagnosis, age at the start of treatment with 131-I-MIBG, the cumulative dose of 131-I-MIBG, and the time elapsed between the dose and the thyroid profile among the cases with or without thyroid dysfunction. Con clusions: 56% of patients with neuroblastoma had thyroid dysfunction. Most of the cases with hy pothyroidism were referred when thyroid dysfunction was clinically evident. A thyroid profile should be performed every 6 months, along with an annual endocrinological evaluation during the next 5 years in these patients.


Subject(s)
3-Iodobenzylguanidine/adverse effects , Hypothyroidism/etiology , Iodine Radioisotopes/adverse effects , Neuroblastoma/radiotherapy , Radiopharmaceuticals/adverse effects , 3-Iodobenzylguanidine/therapeutic use , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Hypothyroidism/diagnosis , Hypothyroidism/epidemiology , Infant , Iodine Radioisotopes/therapeutic use , Male , Radiopharmaceuticals/therapeutic use , Retrospective Studies , Risk Factors , Thyroid Diseases
7.
Inorg Chem ; 58(18): 12083-12098, 2019 Sep 16.
Article in English | MEDLINE | ID: mdl-31456403

ABSTRACT

An alternative synthesis for M(κ2-bipy)4 (M = La, Ce) and [Li(thf)4][M(κ2-bipy)4] (M = Tb, Dy) and the crystal structures for M = La, Ce, and Tb are described. The isomorphous and isostructural neutral molecules, M = La and Ce, are polymeric in the solid-state, as are those of M = Sm and Eu, which were reported in earlier work. The polymeric network is built from eight coordinate units whose geometry in all four cases is that of a square prism. The known molecules, M = Yb and Lu, are also polymeric, but the eight coordinate units have dodecahedral geometries. The structure of the anions in the separated ion pair, [Li(thf)4][M(κ2-bipy)4], in which Tb is reported in this work and Lu is known, are monomeric with geometries that are between that of a square antiprism and a dodecahdron. The electronic structure, from CASSCF multireference quantum mechanical calculations, shows that the electronic ground states for M = La and Lu are multiconfigurational spin doublets and those for the M = Ce and Yb are multiconfigurational spin triplets. This is confirmed by magnetic susceptibility studies as a function of temperature that are consistent with the metals (La, Ce, Sm, Tb, Dy, Yb, and Lu) being trivalent, as are the LIII-edge XANES spectra (Ce, Yb), and divalent for Eu. The multiconfigurational nature of the ground states, developed from CASSCF molecular orbital calculations, renders a single Lewis structure and a single reference molecular orbital representation misleading. The results from the multireference calculations are extended to the other lanthanide molecules and are the genesis of a new model for understanding the magnetic properties of these molecules.

8.
J Pediatr Hematol Oncol ; 41(6): 468-472, 2019 08.
Article in English | MEDLINE | ID: mdl-31033786

ABSTRACT

INTRODUCTION: In children with acute leukemia, gut microbiota is modified secondary to chemotherapy administration, leading to gastrointestinal side effects. Probiotics are microorganisms that can restore gut microbiota and may help alleviate gastrointestinal symptoms. The aim of this pilot study was to assess the effects of probiotic supplementation on chemotherapy-induced gastrointestinal side effects in children with acute leukemia (AL). METHODS: In this randomized pilot study, patients under 17 years of age diagnosed with AL who were on remission induction or remission reinduction chemotherapy were randomly assigned to receive probiotic supplementation (a concentration of 5×109 CFU per sachet was administered at a standard dose twice daily, by mouth) or no probiotic supplementation. The primary endpoint was the prevalence of gastrointestinal side effects. Vomiting, nausea, flatulence, dyspepsia, diarrhea, constipation, abdominal pain, and abdominal distention were assessed in both groups. RESULTS: Gastrointestinal side effects were less prevalent in the probiotic group, and 3 of the 8 gastrointestinal side effects (nausea, vomiting, and abdominal distension) significantly decreased in the probiotic group (P<0.05). We found for diarrhea a relative risk of 0.5 (95% confidence interval [CI], 0.2-1.2; P=0.04); for nausea an RR of 0.5 (95% CI, 0.4-0.8; P=0.04) and for vomiting an RR of 0.4 (95% CI, 0.2-0.9; P=0.04). CONCLUSIONS: Daily supplementation with Lactobacillus rhamnosus reduced chemotherapy-induced gastrointestinal side effects in children with AL.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Dietary Supplements , Gastrointestinal Diseases/prevention & control , Leukemia/drug therapy , Probiotics/therapeutic use , Acute Disease , Case-Control Studies , Child , Female , Follow-Up Studies , Gastrointestinal Diseases/chemically induced , Humans , Leukemia/pathology , Male , Pilot Projects , Prognosis
9.
Inorg Chem ; 57(5): 2843-2850, 2018 Mar 05.
Article in English | MEDLINE | ID: mdl-29424528

ABSTRACT

We report the results of Born-Oppenheimer molecular dynamics (BOMD) simulations on the aqueous solvation of the SmI3 molecule and of the bare Sm3+ cation at room temperature using the cluster microsolvation approach including 37 and 29 water molecules, respectively. The electronic structure calculations were done using the M062X hybrid exchange-correlation functional in conjunction with the 6-31G** basis sets for oxygen and hydrogen. For the iodine and samarium atoms, the Stuttgart-Köln relativistic effective-core potentials were utilized with their associated valence basis sets. When SmI3 is embedded in the microsolvation environment, we find that substitution of the iodine ions by water molecules around Sm(III) cannot be achieved due to an insufficient number of explicit water molecules to fully solvate the four separate metal and halogen ions. Therefore, we studied the solvation dynamics of the bare Sm3+ cation with a 29-water molecule model cluster. Through the Sm-O radial distribution function and the evolution of the Sm-O distances, the present study yields a very tightly bound first rigid Sm(III) solvation shell from 2.3 to 2.9 Å whose integration leads to a coordination number of 9 water molecules and a second softer solvation sphere from 3.9 to 5 Å with 12 water molecules. No water exchange processes were found. The theoretical EXAFS spectrum is in excellent agreement with the experimental spectrum for Sm(III) in liquid water. The strong differences between the solvation patterns of Sm(III) vs Sm(II) are discussed in detail.

10.
J Chem Phys ; 149(14): 144301, 2018 Oct 14.
Article in English | MEDLINE | ID: mdl-30316272

ABSTRACT

We address the aqueous microsolvation of the CH3HgCl and CH3HgOH molecules using a stepwise hydration scheme including up to 33 water molecules and compare our results with the previously studied HgCl2, HgClOH, and Hg(OH)2 complexes. Optimized geometries and Gibbs free energies were obtained at the B3PW91/aug-RECP(Hg)-6-31G(d,p) level. At least 33 water molecules were required to build the first solvation shell around both methylmercury compounds. Optimized geometries were found having favorable interactions of water molecules with Hg, Cl, and the OH moiety. Born-Oppenheimer molecular dynamics simulations were performed on the largest CH3HgX(X = Cl, OH)-(H2O)33 clusters at the same level of theory. Born-Oppenheimer molecular dynamics simulations at T = 300 K (ca. 0.62 kcal/mol) revealed the presence of configurations with hydrogen-bonded networks that include the OH moiety in CH3HgOH and exclude both the Hg and Cl in CH3HgCl, favoring a clathrate-type structure around the methyl moiety. The comparison to the microsolvated HgClOH, Hg(OH)2, and HgCl2 molecules showed that, in all cases, the water molecules easily move away from Cl, thus supporting the idea that HgCl2 behaves as a non-polar solute. The theoretical (LIII edge) X-ray absorption near edge structure spectra are obtained and found in good agreement with experimental data, especially for the CH3HgCl species.

11.
BMC Infect Dis ; 17(1): 478, 2017 07 07.
Article in English | MEDLINE | ID: mdl-28687071

ABSTRACT

BACKGROUND: Leishmaniasis is a protozoan disease caused by parasites of the genus Leishmania, transmitted to humans by sandflies. The diagnosis of leishmaniasis is often challenging as it mimics many other infectious or malignant diseases. The disease can present in three ways: cutaneous, mucocutaneous, or visceral leishmaniasis, which rarely occur together or consecutively. CASE PRESENTATION: The patient was a 52 years old immunosuppressed Belgian woman with a long history of severe rheumatoid arthritis. She underwent bone marrow biopsy to explore thrombocytopenia. Diagnosis of visceral leishmaniasis was made by identification of Leishman Donovan (LD) bodies in macrophages. Treatment with liposomal amphotericin B was successful. She later developed cutaneous leishmaniasis treated with amphotericin B lipid complex. She next presented with relapsing cutaneous lesions followed by rapidly progressing lymphadenopathies. Biopsy confirmed the diagnosis of leishmaniasis. Treatments by miltefosine, amphotericin B, N-methyl-glucamine antimoniate were subsequently initiated. She later presented a recurrent bone marrow involvement treated with intramuscular paromomycin and miltefosine. She died two years later from leukemia. At the time of death, she presented with a mucosal destruction of the nose. A Leishmania-specific PCR (Polymerase Chain Reaction) identified L. infantum as etiological agent. CONCLUSIONS: Clinicians should be aware of the potential concomitant or sequential involvement of multiple anatomic localizations of Leishmania in immunosuppressed patients.


Subject(s)
Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/drug therapy , Amphotericin B/therapeutic use , Antiprotozoal Agents/therapeutic use , Biopsy , Female , Humans , Immunocompromised Host , Leishmania/genetics , Leishmania/pathogenicity , Macrophages/parasitology , Middle Aged , Paromomycin/therapeutic use , Phosphorylcholine/analogs & derivatives , Phosphorylcholine/therapeutic use , Polymerase Chain Reaction , Recurrence
12.
Ophthalmic Physiol Opt ; 36(1): 5-12, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26353999

ABSTRACT

PURPOSE: Dynamic retinoscopy (DR) is a procedure for assessing the accommodative response using a standard clinical instrument. The present study compared measurements of the amplitude of accommodation (AA) obtained using this technique with two subjective methods (modified push-down and minus lens). Additionally, the expected ranges for AA when measured by DR were determined. METHOD: AA was measured in 1298 subjects between 5 and 60 years of age using the three techniques described above. Subjects were grouped into 5-year bins, and a descriptive univariate analysis of the data performed. Goodness-of fit plots were constructed to examine the overall model fit. Centile curves were calculated from the final model. RESULTS: Mean values of AA obtained using DR were significantly lower than for the two subjective techniques. For the DR findings, no significant change was observed between 5 and 19 years of age (mean AA = 8.3 D) and between 45 and 60 years of age (mean AA = 0.6 D). AA values as a function of age were best fit by the polynomial regression equation: logAA = 1.93 + 0.49(age) - 0.19(age)(2) . CONCLUSION: Measurements of AA determined using DR are significantly lower than the normative subjective findings published previously. This difference is at least partly due to the depth-of-field of the eye. These norms markedly overestimate accommodative responsivity. DR provides a simple technique for quantifying accommodation in the clinical setting.


Subject(s)
Accommodation, Ocular/physiology , Aging/physiology , Retinoscopy/methods , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Lens, Crystalline , Male , Middle Aged , Presbyopia/physiopathology , Refraction, Ocular/physiology , Regression Analysis , Visual Acuity , Young Adult
13.
Phys Chem Chem Phys ; 17(46): 31044-54, 2015 Dec 14.
Article in English | MEDLINE | ID: mdl-26530878

ABSTRACT

In many cases the stability of a protein has to be increased to permit its biotechnological use. Rational methods of protein stabilization based on optimizing electrostatic interactions have provided some fine successful predictions. However, the precise calculation of stabilization energies remains challenging, one reason being that the electrostatic effects on the unfolded state are often neglected. We have explored here the feasibility of incorporating Poisson-Boltzmann model electrostatic calculations performed on representations of the unfolded state as large ensembles of geometrically optimized conformations calculated using the ProtSA server. Using a data set of 80 electrostatic mutations experimentally tested in two-state proteins, the predictive performance of several such models has been compared to that of a simple one that considers an unfolded structure of non-interacting residues. The unfolded ensemble models, while showing correlation between the predicted stabilization values and the experimental ones, are worse than the simple model, suggesting that the ensembles do not capture well the energetics of the unfolded state. A more attainable goal is classifying potential mutations as either stabilizing or non-stabilizing, rather than accurately calculating their stabilization energies. To implement a fast classification method that can assist in selecting stabilizing mutations, we have used a much simpler electrostatic model based only on the native structure and have determined its precision using different stabilizing energy thresholds. The binary classifier developed finds 7 true stabilizing mutants out of every 10 proposed candidates and can be used as a robust tool to propose stabilizing mutations.


Subject(s)
Models, Molecular , Proteins/chemistry , Hydrogen-Ion Concentration , Kinetics , Mutation , Osmolar Concentration , Protein Unfolding , Proteins/genetics , Proteins/metabolism , Temperature , Thermodynamics
14.
Int J Biol Macromol ; 255: 128078, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37972836

ABSTRACT

Disintegrins are a family of cysteine-rich small proteins that were first identified in snake venom. The high divergence of disintegrins gave rise to a plethora of functions, all related to the interaction with integrins. Disintegrins evolved to interact selectively with different integrins, eliciting many physiological outcomes and being promising candidates for the therapy of many pathologies. We used NMR to determine the structure and dynamics of the recombinant disintegrin jarastatin (rJast) and its interaction with the cancer-related integrin αVß3. rJast displayed the canonical fold of a medium-sized disintegrin and showed complex dynamic in multiple timescales. We used NMR experiments to map the interaction of rJast with αVß3, and molecular docking followed by molecular dynamics (MD) simulation to describe the first structural model of a disintegrin/integrin complex. We showed that not only the RGD loop participates in the interaction, but also the N-terminal domain. rJast plasticity was essential for the interaction with αVß3 and correlated with the main modes of motion depicted in the MD trajectories. In summary, our study provides novel structural insights that enhance our comprehension of the mechanisms underlying disintegrin functionality.


Subject(s)
Disintegrins , Integrin alphaVbeta3 , Disintegrins/chemistry , Integrin alphaVbeta3/metabolism , Molecular Docking Simulation , Amino Acid Sequence , Integrins/metabolism
15.
J Anim Sci ; 1022024 Jan 03.
Article in English | MEDLINE | ID: mdl-38558022

ABSTRACT

Variation in feed intake results in nearly 20% of sows consuming less than the recommended lysine (Lys) intake for lactating sows. The Lys requirement for lactating sows is based on litter size and piglet average daily gain which influences milk production. Litter size continues to increase every year causing the need for routine reevaluation of nutrient requirements. If dietary inclusion levels are not continuously adjusted this can lead to inadequate daily Lys and energy intake and may negatively impact sow body condition and litter performance. The objective was to characterize the average daily feed intake (ADFI) of sows and define feed intake patterns and their effects on sow body weight, farrowing performance, litter performance, and subsequent farrowing performance. ADFI during lactation was recorded for 4,248 sows from 7 independent research studies. Data collection occurred from November 2021 through November 2023 at a commercial breed-to-wean facility in western Illinois. Each sow was categorized as: consistently low intake (< 5.5 kg/d) throughout the lactation (LLL); low intakes (< 5 kg/d) in the first week, then gradually increased throughout the rest of the lactation period (LHH); gradual increase in intake throughout lactation with no drop and a peak intake after day 10 of lactation (gradual); rapid increase in intake with no drop and the peak intake met before day 10 (rapid); a major drop in feed intake (> 1.6 kg decrease for ≥ 2 d) any time during lactation (MAJOR); minor drop (≤ 1.6 kg for ≥ 2 d; MINOR). Sows were also separated into low (quartile 1; ≤ 25%), average (quartile 2 through 3), or high feed intake (quartile 4; ≥ 75%) by parity (P1, P2, P3+). Sows in the LLL category were younger in parity, had the greatest preweaned mortality, weaned the lightest average pigs, and experienced the greatest loss in body weight percentage compared with sows in all other feed intake categories. Furthermore, sows in the LLL and LHH categories had one fewer subsequent pig born compared with sows in the other four categories. These data support historical findings that feed intake patterns directly contribute to current litter farrowing performance. Lactation intake patterns also influence subsequent farrowing performance. Identifying under-consuming sows that are likely Lys and energy deficient allows producers opportunities to promote consistent, adequate daily intakes to these groups and mitigate negative impacts on sow and litter performance.


This study investigated different sow feed intake patterns during lactation and average daily feed intakes within parity on current and subsequent farrowing and litter performance. Findings revealed sows that have consistently low intake throughout the lactation period have a significant reduction in average pig wean weight, a greater percentage of pre-wean mortality, and take an additional day or longer to return to estrus compared with sows that have average or above feed intake throughout the lactation period. Specifically, older parity sows were heavier, had greater feed intake, nursed heavier litters, and had litters with less preweaned mortality compared with younger parity sows. The average pig weaned weight and subsequent total pigs born improved as intake increased within parity. Prewean mortality decreased as feed intake increased within parity. These findings highlight the importance of ensuring sows are not only eating enough, but that they are consuming more than average when possible, to continually improve current and subsequent farrowing and litter performance. This study provides important information that will allow producers to target specific under-consuming sows and then promote consistent and high daily lactation intakes. Targeting these potentially nutrient-restricted sows may help reduce negative impacts on sow and litter performance.


Subject(s)
Animal Feed , Eating , Lactation , Animals , Female , Lactation/physiology , Swine/physiology , Pregnancy , Animal Feed/analysis , Diet/veterinary , Litter Size , Animal Nutritional Physiological Phenomena
16.
JACC Case Rep ; 29(4): 102210, 2024 Feb 21.
Article in English | MEDLINE | ID: mdl-38379656

ABSTRACT

We present a case of a full-term newborn with complex congenital heart defects, including single-ventricle physiology and discontinuous pulmonary arteries. Prompt surgical intervention was performed, which involved pulmonary neoconfluence with autologous pericardium graft and systemic-to-pulmonary shunt placement. However, postoperative complications required stenting to address pulmonary artery stenosis.

17.
Anticancer Res ; 44(5): 1955-1962, 2024 May.
Article in English | MEDLINE | ID: mdl-38677771

ABSTRACT

BACKGROUND/AIM: The epidermal growth factor receptor (EGFR) is over-expressed in several types of cancer, and monoclonal antibody therapy has been the strategy that has shown the best results. This study focused on the construction of a humanized single chain antibody (huscFv) directed against EGFR (HER1). MATERIALS AND METHODS: The CDR grafting method was used to incorporate murine complementarity determining regions (CDRs) of cetuximab into human sequences. A dot blot assay was used to examine the affinity of the huscFv secreted by HEK293T for EGFR. The inhibitory effect on the viability of A549 cells was evaluated using the WST-1 assay. RESULTS: The incorporation of murine CDRs of cetuximab into human sequences increased the degree of humanness by 16.4%. The increase in the humanization of scFv did not affect the affinity for EGFR. Metformin had a dose-dependent effect, with an IC50 of 46 mM, and in combination with huscFv, the cell viability decreased by 45% compared to the 15% demonstrated by huscFv alone. CONCLUSION: The CDR grafting technique is efficient for the humanization of scFv, maintaining its affinity for EGFR and demonstrating its inhibitory effect when combined with metformin in A549 cells.


Subject(s)
Cetuximab , ErbB Receptors , Metformin , Single-Chain Antibodies , Animals , Humans , Mice , A549 Cells/drug effects , Antibodies, Monoclonal, Humanized/pharmacology , Cell Survival/drug effects , Cetuximab/pharmacology , Complementarity Determining Regions/immunology , ErbB Receptors/immunology , ErbB Receptors/antagonists & inhibitors , HEK293 Cells , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Lung Neoplasms/immunology , Metformin/pharmacology , Single-Chain Antibodies/pharmacology , Single-Chain Antibodies/immunology
18.
Toxins (Basel) ; 16(3)2024 Mar 08.
Article in English | MEDLINE | ID: mdl-38535808

ABSTRACT

Central America is home to one of the most abundant herpetofauna in the Americas, occupying only 7% of the continent's total area. Vipers and lizards are among the most relevant venomous animals in medical practice due to the consequences of envenomation from the bite of these animals. A great diversity of biomolecules with immense therapeutic and biotechnological value is contained in their venom. This paper describes the prominent leading representatives of the family Viperidae, emphasizing their morphology, distribution, habitat, feeding, and venom composition, as well as the biotechnological application of some isolated components from the venom of the animals from these families, focusing on molecules with potential anti-thrombotic action. We present the leading protein families that interfere with blood clotting, platelet activity, or the endothelium pro-thrombotic profile. In conclusion, Central America is an endemic region of venomous animals that can provide many molecules for biotechnological applications.


Subject(s)
Thrombosis , Animals , Central America , Blood Coagulation , Biotechnology , Blood Platelets
19.
Anticancer Res ; 44(6): 2567-2575, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38821612

ABSTRACT

BACKGROUND/AIM: Protein phosphatase and tensin homolog (PTEN) is a tumor suppressor protein with potential to be a new biotechnological drug for PTEN-deficient cancer treatment. This study aimed to develop PTEN-based chimeric proteins (CPP-PTEN-THP) for human epidermal growth factor receptor 2 (HER2)-positive breast cancer treatment, addressing current limitations like inadequate delivery, poor tumor penetration, and low selectivity, while assessing their potential HER2-specific anticancer effects. MATERIALS AND METHODS: pCEFL-EGFP vector was used for both TAT-PTEN-LTV and KLA-PTEN-LTV construction. Non-contact co-cultures were employed using HEK-293T cells for protein expression, and HCC-1954 and MCF-7 cell lines for cytotoxicity testing. Protein detection was analyzed by western blotting and a docking prediction analysis was performed to infer the interactions. RESULTS: Endogenous and recombinant PTEN protein expression was confirmed in cell lysates. A 54-kDa signal matching the theoretical size of PTEN was detected, showing a greater level in TAT-PTEN-LTV (215.1±26.45%) and KLA-PTEN-LTV (129.2±1.44%) compared to endogenous PTEN. After the noncontact co-culture method, cytotoxic studies showed HCC-1954 preferential cell inhibition growth, with 25.95±0.9% and 12.25±1.29% inhibition by KLA-PTEN-LTV and TAT-PTEN-LTV respectively, compared to MCF-7 cells. An LTV-HER2 interaction model was proposed, inferring that LTV interactions are mainly due to the Pro, Trp, and Tyr residues that target HER2. CONCLUSION: The developed PTEN-based chimeric proteins have HER2-specific anticancer activity against HCC-1954 cells.


Subject(s)
PTEN Phosphohydrolase , Receptor, ErbB-2 , Recombinant Fusion Proteins , Humans , PTEN Phosphohydrolase/metabolism , PTEN Phosphohydrolase/genetics , Receptor, ErbB-2/metabolism , Receptor, ErbB-2/genetics , Recombinant Fusion Proteins/pharmacology , Recombinant Fusion Proteins/metabolism , Recombinant Fusion Proteins/genetics , Antineoplastic Agents/pharmacology , Cell Line, Tumor , HEK293 Cells , MCF-7 Cells , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Breast Neoplasms/genetics , Female , Molecular Docking Simulation , Coculture Techniques
SELECTION OF CITATIONS
SEARCH DETAIL